Sanofi Pasteur Korea launches DTaP-IPV combo vaccines

Published: 2010-01-13 06:57:00

Updated: 2010-01-13 06:57:00

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, says it has launched Tetraxim, a DTaP-IPV combined vaccine as a three-dose primary vaccination at 2, 4 and 6 months of age.

"Our DTaP vaccine will help simplify the immunization schedule by reducing the number of injections infants...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK